Startseite>>Signaling Pathways>> Microbiology & Virology>> Fungal>>Tolnaftate

Tolnaftate (Synonyms: NSC 233648, SCH 10144)

Katalog-Nr.GC10337

Tolnaftat (NP-27) ist ein synthetisches Thiocarbamat, das als Antimykotikum verwendet wird.

Products are for research use only. Not for human use. We do not sell to patients.

Tolnaftate Chemische Struktur

Cas No.: 2398-96-1

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
35,00 $
Auf Lager
50mg
48,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent. .

Tolnaftate (NP-27) blocked sterol biosynthesis in fungal cells and cell extracts, with accumulation of squalene. This point of action was confirmed by the direct inhibition of microsomal squalene epoxidase from Candida albicans[1]. Tolnaftate (NP-27) inhibited sterol biosynthesis, At 100 microM, tolnaftate caused up to a 30% release of intracellular [14C]aminoisobutyric acid[2].

References:
[1]. Ryder, N.S., I. Frank, and M.C. Dupont, Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate. Antimicrob Agents Chemother, 1986. 29(5): p. 858-60.
[2]. Georgopapadakou, N.H. and A. Bertasso, Effects of squalene epoxidase inhibitors on Candida albicans. Antimicrob Agents Chemother, 1992. 36(8): p. 1779-81.

Bewertungen

Review for Tolnaftate

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tolnaftate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.